The Benefits To Chiropractic Care On The Health Care System

Chiropractic care has measurable results. Below we look at some actual data for how chiropractic medicine is making people healthier.

Whenever you truly look into the impact, properly designed and delivered, Chiropractic care has on health and health care, you come up with one answer: It works!  The challenge is, it’s not a trillion dollar industry like the drug industry.  As a result, it doesn’t have the finances to do millions of dollars of research to keep driving this truth home.

Generally, when a medical process shows promising results, millions are invested to follow up with it and determine just how far you can go, how many lives can be impacted, and what would be the net result on the health care industry.  Clearly, as you look at what are thousands of positive outcomes of Chiropractic studies, it “warrants further investigation.”  Just to keep you up to speed on a few of the really interesting outcomes Chiropractic has had on people and health care – take a look below:

Quality of Life

  •  95%  reported their expectations had been met
  • 99% wished to continue care
  • 2,818 respondents in 156 practices

Blanks, Shuster and Dobson.  JVSR 1997;1(4):15.

Senior Citizens Over 75 Years of Age

  •  Chiropractic vs. non-chiropractic patients in an insurance data base.
  •  Reported better overall health, fewer prescription drugs, and more activity.
  •  21% less time in hospitals over last 3 years.

Coulter, et al.  Topics in Clinical Chiropractic 1996;3(2):46.

Senior Citizens Over 65 Years of Age

  •  Had “maintenance care” for 5 years or longer.
  •  50% fewer medical provider visits.
  •  31% of national average for health care services.
  •  95.8% felt care “considerably” or “extremely” valuable.

Rupert, Manello and Sandefur. JMPT 2000;23(1):10.

HMO Illinois: BC/BS
Primary care DCs

  •  60.2% decrease in hospital admissions
  •  59% decrease in hospital days
  •  62% decrease in outpatient surgeries and procedures, and
  •  85% reduction in pharmaceutical costs off compared to normative values.